International Biotechnology Trust (LSE:IBT) Cash-to-Debt : 0.33 (As of Feb. 2024)

View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. International Biotechnology Trust's cash to debt ratio for the quarter that ended in Feb. 2024 was 0.33.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, International Biotechnology Trust couldn't pay off its debt using the cash in hand for the quarter that ended in Feb. 2024.

The historical rank and industry rank for International Biotechnology Trust's Cash-to-Debt or its related term are showing as below:

LSE:IBT' s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: 0.06 Max: No Debt
Current: 0.33

During the past 13 years, International Biotechnology Trust's highest Cash to Debt Ratio was No Debt. The lowest was 0.00. And the median was 0.06.

LSE:IBT's Cash-to-Debt is ranked worse than
70.9% of 1450 companies
in the Asset Management industry
Industry Median: 5.72 vs LSE:IBT: 0.33

International Biotechnology Trust Cash-to-Debt Historical Data

The historical data trend for International Biotechnology Trust's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

International Biotechnology Trust Cash-to-Debt Chart

International Biotechnology Trust Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

0.02

0.07

International Biotechnology Trust Semi-Annual Data
	Aug14	Feb15	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24
Cash-to-Debt	Get a 7-Day Free Trial															-	-	-	-	0.33

Competitive Comparison of International Biotechnology Trust's Cash-to-Debt

For the Asset Management subindustry, International Biotechnology Trust's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

International Biotechnology Trust's Cash-to-Debt Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, International Biotechnology Trust's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's Cash-to-Debt falls into.

International Biotechnology Trust Cash-to-Debt Calculation

This is the ratio of a company's Balance Sheet Cash And Cash Equivalents to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

International Biotechnology Trust's Cash to Debt Ratio for the fiscal year that ended in Aug. 2023 is calculated as:

Cash to Debt Ratio	=	Balance Sheet Cash And Cash Equivalents	/	Total Debt
	=	Balance Sheet Cash And Cash Equivalents	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0	/	(0	+	32.474)
	=	0.00

International Biotechnology Trust's Cash to Debt Ratio for the quarter that ended in Feb. 2024 is calculated as:

Cash to Debt Ratio	=	Balance Sheet Cash And Cash Equivalents	/	Total Debt
	=	Balance Sheet Cash And Cash Equivalents	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	9.227	/	(0	+	27.669)
	=	0.33

International Biotechnology Trust (LSE:IBT) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

International Biotechnology Trust Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

International Biotechnology Trust (LSE:IBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

IBTl:UK

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.ibtplc.com

International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust (LSE:IBT) Headlines

No Headlines